Saffron is one of the most expensive spices in the world (20,000 €/kg) and this is due not only to the high demand for its various uses such as cooking, production of staining medicines, cosmetics etc., but also for the high costs of cultivation and production. Several studies have demonstrated that differences in saffron quality are mainly due to the methodology followed in the processing of stigmas, and environmental conditions independent of the origin. Some authors found phenotypic variations within cultivated saffron, but very limited genetic diversity. The reason for the very limited genetic diversity in cultivated saffron is explained by its asexual mode of reproduction (propagation). The aim of this study was to assess the antimicrobial activity of stigma saffron, which were tested against different bacteria strains. The results obtained from the antimicrobial activity study indicate that stigmas of C. sativus have some antimicrobial effect.
Introduction
Crocus sativus L. (saffron) belongs to the Iridaceae (Liliales, Monocots) family, it is a sterile triploid (2n=3x=24) species that is propagated vegetatively via its corms which undergo a period of dormancy. 1 At least 85 species are known to belong to the Crocus genus and C. sativus is the most interesting one, not only as source of spice for cooking but also as basic compound in cosmetics and medicine. Several archeological studies locate the probable saffron centre of origin in Iran and Kashmir even if, recently, some authors have identified Crete as the primary centre of domestication during the Late Bronze Age. [2] [3] [4] [5] In fact, even though the botanical origins of C. sativus have not yet been completely clarified, some authors have identified C. cartwrightianus (2n = 16), which grows in the southern Greece and in the neighbouring islands, and C. oreocreticus (ibid.), which grows in Crete, as putative fertile diploid progenitors. 6 Saffron was introduced in to the Greek and Roman world by Phoenicians and later Arabs and Moors brought it to Spain. 2, 5, 7 Many Greek, Roman and Egyptian historians, described the use of saffron as a precious component to stain cloth, to enrich the taste of food and drinks and for use in medical therapy. 6, 8, 9 The pharmacological effects of saffron components such as safranal and crocin are well known and widely used in medicine. Several studies on the biological activities of these constituents have highlighted the beneficial therapeutic effects and are often used to support traditional medical therapies in various diseases. 10 Crocin, and safranal have displayed important antioxidant properties that prevent gastric disorders like ulcer formation and stomach lesion. 11, 12 These compounds are also used to prevent cardiovascular disease, insulin resistance, depression, premenstrual syndrome, insomnia and anxiety. [13] [14] [15] [16] [17] [18] [19] [20] [21] Studies on the antimicrobial properties of saffron active compounds are few, several authors have been reported the anti-bacterial activity of aqueous and methanolic extracts of crocin and safranal against Helicobacter pylori. 22, 23 An interesting anti-bacterial effects of the same active compounds on stigma contamination by Salmonella during storage at room temperature was observed. 24 The absence of Salmonella on saffron spice coming from the main producer countries (Greece, Iran, Italy, Morocco, and Spain) has also been observed. 25 Despite the high production costs, saffron cultivation is widespread throughout the world and it is currently cultivated not only in Anatolia but also in China, India, Turkey, Europe, Africa and more recently in Mexico and Australia. 26 Total world saffron production is estimated at about 220,000 tons, of which about 90% is produced in Iran (Khorasan Province) and the rest in Greece, Spain, Italy and India (Kashmir). [27] [28] [29] The components of the spice saffron are localized in the red stigmatic lobes of C. sativus flower and these are responsible for its distinct color, flavor and smell. 30 The commercial spice is obtained from dried stigmas and marketed as saffron filaments or as powder from milled stigmas. Saffron is one of the most expensive spices in the world (20,000 €/kg), 31 and this is due not only to the of the high demand for its various uses such as cooking, or for the production of staining medicines, cosmetics, etc. 7 but also for the high costs of cultivation and production. In order to gather the saffron, stigmas of the C. sativus flowers must be handpicked. This is time consuming; usually to obtain 1 gram of saffron, an average of 150 flowers must be collected. 32 Many researches have demonstrated that differences in saffron quality are mainly due to the methodology used in the processing stigmas and, independent from the origin of the species quality is also influenced by sowing time and environmental conditions. [33] [34] [35] Several studies have found phenotypic variations within cultivated saffron, such as flower size, shape of the tepals, differences of colour and intensity in the tepals of samples collected from different areas, but very limited genetic diversity has been observed. 34, [36] [37] [38] The very reduced genetic diversity existent in cultivated saffron is attributed to its asexual propagation, and by successive selection during breeding. 36 However, other factors that may have contributed to the low level of molecular polymorphisms found are related to the marker techniques that have been applied. 39, 40 In an attempt to determine possible antimicrobial properties of saffron, the aim of this study was to assess the antimicrobial 
Materials and Methods

Plant material
Iranian (6 accessions) and Italian corms (2 accessions) were planted in September 2012 on a sandy-clay soil in Umbria, Central Italy (220 m a.s.l.). Sowing was executed in raised beds at 20 cm depth 50 cm between rows and 20 cm between corms in rows. A complete randomized block design with two replicates was adopted. Fifteen corms per accession per replication were used; no fertilizer and no irrigation were applied. Weeds were managed by hand.
For antimicrobial activity, stigmas of C. sativus collected from Torbat-e Heydarieh (Iran) (sample "A"), Gonabad (sample "B") and Khorasan (sample "C"), dried with the traditional technique of flow of hot air emitted from a ventilated oven were used. Water-washed stigmas were shade dried at room temperature and powdered by manual blender. 1g of each of the dried and powdered materials were macerated separately with sterile water at a concentration of 100 mg/100 ml.
The bacterial strains used for the test were taken from the collection of the Laboratorio di Ispezione degli Alimenti di Origine Animale (University of Perugia: Escherichia coli, strain CSH26 K-12; Enterococcus faecalis, strain NCTC 12201; and Staphylococcus aureus, strain 27R. The microorganisms were grown aerobically in Nutrient Broth (NB; CM0001, Oxoid, Basingstoke, UK) at 37 °C for 24 h. The total viable cell count on Nutrient Agar (NA; CM0003, incubated at 37 °C on air for 24 h; Oxoid) at 24 h was approximately 10 9 cfu ml -1 . Decimal dilutions were performed to obtain the following concentrations in NB: 10 6 cfu ml -1 , 10 5 cfu ml -1 , 10 4 cfu ml -1 , and 10 3 cfu ml -1 . The total viable cell counts for all dilutions were recorded as controls on NA and on the following media. Violet red bile glucose agar (CM0485, Oxoid), was used for counts of E. coli, Enterococcus agar (CM0984, Oxoid) was used for E. faecalis, Oxacillin Resistance Screening Agar base (ORSAB; CM1008, Oxoid) with ORSAB selective supplement (SR019, Oxoid) was used for S. aureus.
Antimicrobial screening with a modified well plate test
Antimicrobial activity was determined using a modified well plate method. 41 Muller Hinton agar (Oxoid, Basingstoke, UK) was used for the growth of bacterial strains. Each organism was separately suspended in a normal saline solution and transmittance (T) of 75-77% at 530 nm was made, which is equal to 10 6 cfu ml-1 . Each plate was inoculated with 0.2 ml of microbial suspension. 100μl of "A", "B", and "C" sample extracts, respectively, were added to each well and incubated at 37 ºC for 24h. The positive antimicrobial activity was evaluated based on growth inhibition zone and compared with the control. The extracts were then diluted in a two-fold manner to make different concentrations. 100μl of the active extracts were then added to each well. All the tests were repeated in duplicates.
Vitality reduction
Vitality reduction activity was performed for E. coli, strain CSH26 K-12; E. faecalis, strain NCTC 12201; and S. aureus, strain 27R, using the BS EN 1040:2005. 42 Experimental conditions were validated as follows: 1 ml of sterile water and 1 ml of bacterial validation suspension containing 3.0 10 2 to 1.6 10 3 cfu ml -1 were placed in a test tube. The components were left in contact for 2 minutes; then 8 ml of water were added and left in contact at the temperature adopted during the assay for the longest period to be tested (see below). At the end of the contact time, the mixture was vortexstirred and a double count was performed by inclusion in agar. The number of colonyforming units per ml of the mixture was determined following incubation for 48 hours at 37 ± 1°C. The bacterial suspension showing concentrations in a 1.5 10 5 to 5 10 5 cfu ml -1 range were diluted up to 10 6 and 10 7 . A double counting through inclusion in agar was performed. The number of colonyforming units per ml of the suspension was determined following incubation for 48 hours at 37 ± 1°C. For the assay, the bacterial suspension showing concentrations in a 1.5x10 8 to 5x10 8 cfu ml -1 range were diluted up to 10 6 and 10 7 .
A double counting through inclusion in agar was performed. The number of colonyforming units per ml of the suspension was determined following incubation for 48 hours at 37°C ± 1°C and N value was calculated.
The assay sample and the bacterial suspensions had previously been stabilised at the test temperature of 20°C ±1°C. For each bacterial strain and for each concentration of the test substance, one test tube containing 1 ml of sterile water and 1 ml of bacterial test suspension showing concentrations in a 1.5x10 8 to 5x10 8 cfu range, was prepared at the temperature adopted during the assay. Alter 2 minutes of contact, 8 ml of the sample extracts "A", "B", and "C" respectively, were added and left in contact again for the selected times at the test temperature. At the end of the contact time (5 minutes), 1 ml of mixture was transferred into a test tube containing 8 ml of distilled water. After 5 minutes of neutralization procedure, the mixture was vortex-stirred and a double count was performed by inclusion in agar.
The number of cfu per plate was determined following incubation for 48 hours at 37°C, and Na value was then calculated.
Statistical data analysis
For antimicrobial activity, the count was performed using the number of colonies counted on both plates. Only the plates showing a number of colonies included in a 15-300 range were used to perform the result calculation. A deviation of 10% is accepted, so the limits are 14 and 330. In the assay, where the number of cfu on every plate counted is <14, the number of cfu/ml was recorded as < 1.4 10 2 . Where the number of cfu on every plate counted was >330, the number of cfu/ml was recorded as >3. 3 10 3 .
Vitality reduction is expressed in logarithm and was calculated for each organism and test concentration using the following formulas:
where N = bacterial counting; c = sum of colonies counted on both plates; n 1 = number of counted plates in the lower dilution; n 2 = number of counted plates in the higher dilution; d = dilution factor corresponding to the lower dilution.
where: R = Reduction of vitality; N 0 = N/10; Na = bacterial counting for the test mixture al the end of the contact time. The higher the value, the higher the vitality reduction.
Results
For the initial antimicrobial screening with the well plate test (Table 1) , S. aureus growth was inhibited by plant extract A and B at the concentration of 1:1 and 1:2; E. faecalis growth was inhibited by extract A and B at the highest concentration. No activity was detected against E. coli and plant extract C had no detectable antimicrobial activity.
Based on the results of antimicrobial screening, the three tester strains were chal- 
Discussion and Conclusions
The results obtained from the antimicrobial activity study indicate that stigmas of C. sativus are a good source of antimicrobial agents. Based on these results, it is possible to conclude that aqueous extracts of stigmas of saffron had a moderate antimicrobial activity. These results might be considered sufficient for further studies on the isolation and identification of the active principles and to evaluate of possible synergism among extract components for their antimicrobial activity. In conclusion, the degree of antibacterial property for aqueous extracts of saffron, yet mild, has been demonstrated. Saffron may be selected for use as potential anti-microbial agent in various food products depending on the desired flavour of the products. However, there are some limitations in using saffron in certain food matrix, such as the decreasing of antimicrobial activity when diluted and the strong flavour. The overall flavour of the products may not be acceptable if a large amount of saffron is needed to achieve a significant inhibition of pathogens and hygiene indicators, especially when the effect of other preservatives is weak. A possible way is to use saffron in combination with other preservatives such as acid, salt, sugar, and other chemical preservatives, or other food preservation systems such as thermal processing, freezing or cold storage. 43 Table 1 . Minimum inhibitory concentration of aqueous extract of saffron stigmas (C. sativus from Torbat-e Heydarieh (sample "A"), Gonabad (sample "B") and Khorasan (sample "C"), Iran. 
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